Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Absence Of Pediatric Plans Put NDAs/BLAs At Risk For Refusal To File

Executive Summary

FDA may refuse to file drug applications that do not include a pediatric plan when sponsors ask for a deferral of pediatric data until after a drug is approved.

You may also be interested in...



Pediatric Study Plans Would Be Required At End Of Phase II Under Bipartisan House Bill

Rather than assessing monetary penalties for violating study deadlines, H.R. 4274 directs FDA to issue warning letters and publish them on its website.

Reauthorizations Cause Sponsor Angst For PREA, BPCA Studies, GAO Finds

The regular reauthorization of PREA and BPCA, when coupled with the long review horizon for pediatric studies at FDA, could be hindering sponsors’ willingness to conduct the trials, according to a Government Accountability Office Report.

Reauthorizations Cause Sponsor Angst For PREA, BPCA Studies, GAO Finds

The regular reauthorization of PREA and BPCA, when coupled with the long review horizon for pediatric studies at FDA, could be hindering sponsors’ willingness to conduct the trials, according to a Government Accountability Office Report.

Related Content

Topics

UsernamePublicRestriction

Register

PS052740

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel